CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 8-K Event Material agreement · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Executive or director change
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award CFO acquired 3,931 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 6,879 shares (grant or award)
- 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 14,741 shares (grant or award)
- 4 Other acquisition Director acquired 8,358 shares (other)
- 4 Other acquisition Director acquired 8,358 shares (other)
- 4 Grant or award CFO acquired 4,789 shares (grant or award)
- 4 Grant or award Dir Govt Relations/Sectry acquired 8,381 shares (grant or award)
- 4 Grant or award Exec.Vice Chairman/CEO/Pres. acquired 17,960 shares (grant or award)
- 8-K Event Material agreement · New debt or obligation
Page 25 of 82 · 1,637 filings